- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
ACADIA Pharmaceuticals Inc
+ Add to WatchlistACAD:US
13.7900 USD 0.3600 2.54%As of 20:10:00 ET on 05/21/2013.
Company Profile for ACADIA Pharmaceuticals Inc (ACAD)
ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.
Contact Information
ACADIA Pharmaceuticals Inc
3911 Sorrento Valley Boulevard
San Diego, CA 92121
United States
Key Executives for ACADIA Pharmaceuticals Inc (ACAD)
| Uli HacksellPresident/CEO | Thomas H AasenExec VP/CFO/Treasurer |
| Roger M MillsExec VP:Dev/Chief Medical Ofcr | Glenn F BaityVP/Secy/General Counsel |
| Lisa BarthelemyDirector:Investor Relations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page